O slideshow foi denunciado.
Utilizamos seu perfil e dados de atividades no LinkedIn para personalizar e exibir anúncios mais relevantes. Altere suas preferências de anúncios quando desejar.
Próximos SlideShares
Intramuscular haemangioma
Intramuscular haemangioma
Carregando em…3
×
1 de 20

Contraception

7

Compartilhar

Baixar para ler offline

Livros relacionados

Gratuito durante 30 dias do Scribd

Ver tudo

Audiolivros relacionados

Gratuito durante 30 dias do Scribd

Ver tudo

Contraception

  1. 1. Contraception The way to evidence
  2. 2. A 42 year‑old woman P5+1 was wearing an IUD for 6 months ,that was removed 2 months ago because of partial expulsion(2nd expulsion)
  3. 3. <ul><li>She is diabetic for 21 years </li></ul><ul><li>Husbanded refuses condom, coitus interrupts or vaginal tablet </li></ul><ul><li>She is seeking for another effective contraceptive method </li></ul><ul><li>What is the best advice ?? </li></ul>
  4. 4. What Is The Best Advice ?? The most suitable& effective? <ul><li>A- E/P vaginal ring: Nuva Ring </li></ul><ul><li>B- Progestagen implant: Implanon </li></ul><ul><li>C:Levonorgestrel IUD : Mirena </li></ul><ul><li>D: Depoprovera </li></ul><ul><li>E: Progesagen only pills </li></ul>B
  5. 5. Contraceptive Choice above the age of 40 years <ul><li>Choice is influenced by : </li></ul><ul><li>Frequency of intercourse </li></ul><ul><li>Natural decline in fertility </li></ul><ul><li>Menstrual dysfunction </li></ul><ul><li>Concurrent medical disorders </li></ul><ul><li>Wish for non-contraceptive benefits </li></ul><ul><li>Acceptance of the couple. </li></ul><ul><li>Age of the couple. </li></ul>
  6. 6. No contraceptive method is contraindicated by age alone. RCOG FFPRHC Guidance Grade C 2005 Women aged over 40 years can be advised that:
  7. 7. Women should be counseled for the risks and non-contraceptive benefits of all contraceptive methods. Medical eligibility criteria for contraceptive ( MECC ) WHO 2004
  8. 8. The WHO Medical Eligibility Criteria The WHO Medical Eligibility Criteria for Contraceptive Use provides evidence-based recommendations to ensure that women can select the most appropriate method of contraception without unnecessary medical barriers. RCOG FFPRHC Guidance Grade C 2005
  9. 9. WHO Medical Eligibility Criteria for Contraceptive Use (WHOMEC) 2004 / 2008 Eligibility rather than ineligibility (or contraindication) : 4 Categories
  10. 10. Category 1: The use is unrestricted (Used in any circumstances) Category 2: The advantages outweigh the theoretical or proven risks. ( Generally can be used) Category 3: The risks outweigh the benefit. (Not used unless other appropriate methods are not available or acceptable) Category 4: The use an unacceptable health risk (Method not to be used)
  11. 11. A. E/P vaginal ring: Nuva Ring <ul><li>Review 12 RCTs </li></ul><ul><li>Superior cycle control than COC </li></ul><ul><li>Lower incidence of nausea and breast tenderness </li></ul><ul><li>Roumen. Contraception, 2007 </li></ul>
  12. 12. <ul><li>May be more effective than proper COC use. </li></ul><ul><li>Long-term studies is limited: but expected that benefits and risks are similar to COC. </li></ul><ul><li>Evidence-based guidance A WHO Family Planning Cornerstone 2007 </li></ul>
  13. 13. B. Progestagen Implants: Implanon Norplant and Implanon
  14. 14. The Implanon rod <ul><li>Core: 40% EVA Copolymer </li></ul><ul><li>60% Etonogestryl </li></ul><ul><li>Membrane: 100% EVA </li></ul><ul><li>EVA: Ethylene Vinyl Acetate </li></ul>
  15. 15. Applicator Obturator cannula
  16. 16. <ul><li>Alleviate menorrhagia, dysmenorrhea & PMT </li></ul><ul><li>Reduce the size of fibroid </li></ul><ul><li>Regression of endometriosis </li></ul><ul><li>Regression of endometrial hyperplasia </li></ul><ul><li>Endometrial protection in HRT. </li></ul><ul><li>Prevention of PID </li></ul><ul><li>Can be left up to 7 years (Normal = 5 y) </li></ul><ul><li>Particularly useful for the perimenopausal woman </li></ul>C. Mirena®
  17. 17. D. Injectables NET-EN and DMPA
  18. 18. C. Progestin only pills (POP)
  19. 19. WHO Medical Eligibility Criteria: Diabetes IUD Mirena PO Implant PO Injectable POP E+P P - I - R 1 1 1 1 1 History of G. Diabetes 2 2 2 2 2 Uncomplicated Diabetes 2 2 2 2 3 Diabetes + other Risk factor 2 2 3 2 4 1-Vascular Diabetes (Nephropathy, Retinopathy, Neuropathy) 2-Diabetes >20 years
  20. 20. What Is The Best Advice ?? <ul><li>A- E/P vaginal ring: Nuva Ring : Eligibility 4 </li></ul><ul><li>B- Implanon Eligibility 2.& FR 0.0- 0.05HWY </li></ul><ul><li>C:Levonorgestrel IUD : Mirena Previous 2 expulsions </li></ul><ul><li>D: Depoprovera Eligibility 3 </li></ul><ul><li>E: Progesagen only pills E ligibility2 & FR:0.5-5HWY </li></ul>B

×